Full Press Release Details
NEW BRUNSWICK, N.J. , Aug. 20, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will host a conference call for investors at 8:00 a.m. (Eastern Time) on Thursday , September 13 th , to review its Pharmaceutical Business. Joaquin Duato, Vice Chairman of the Executive Committee; Jennifer Taubert , Executive Vice President, Worldwide Chairman, Pharmaceuticals; Mathai Mammen , Global Head, Janssen Research & Development and Lesley Fishman , Senior Director Investor Relations will host the call.
Investors and other interested parties can access the webcast/conference call in the following ways:
About Johnson & Johnson At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That's why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world's largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.